BioCentury
ARTICLE | Financial News

Alzheon pulls second IPO attempt

January 18, 2019 8:41 PM UTC

Alzheimer's disease company Alzheon Inc. (Framingham, Mass.) on Jan. 16 withdrew for the second time a planned NASDAQ IPO, according to an SEC filing.

Alzheon first proposed to raise up to $80.5 million on March 16. The company withdrew that proposal May 1. In August, the company then proposed a new IPO seeking $41.2 million...

BCIQ Company Profiles

Alzheon Inc.

BCIQ Target Profiles

Beta amyloid